Insider · CIK 0001833225
Jamie Hodari
Files at CBRE (CBRE GROUP, INC.). First filing -, latest -.
In brief
Jamie Hodari files SEC Form 4 as CEO at CBRE (CBRE GROUP, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jamie Hodari has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | CBRE CBRE GROUP, INC. | FTax withholding Class A Common Stock | -1,120 | $141.19 | $158k | 42,316 | Mar 9, 2026 |
| Feb 25, 2026 | CBRE CBRE GROUP, INC. | AGrant or award Class A Common Stock | +10,583 | $0.00 | $0 | 43,436 | Feb 27, 2026 |
| Feb 20, 2026 | CBRE CBRE GROUP, INC. | AGrant or award Class A Common Stock | +21,902 | $0.00 | $0 | 32,853 | Feb 24, 2026 |
| Mar 5, 2025 | CBRE CBRE GROUP, INC. | AGrant or award Class A Common Stock | +10,951 | $0.00 | $0 | 10,951 | Mar 7, 2025 |
Questions about Jamie Hodari
Answered from the filings on this page, as of the latest one.
Is Jamie Hodari buying or selling?
Jamie Hodari has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jamie Hodari's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jamie Hodari has 0.
Where does Jamie Hodari file Form 4?
Jamie Hodari has filed Form 4 at CBRE (CBRE GROUP, INC.) as CEO, BOE & CCO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.